Member Blog: Common Cannabis Capital Cadence
by Sumit Mehta, CEO of MAZAKALINCIA’s Finance and Insurance Committee Companies often benefit from capital infusions that can help them grow their businesses. When and how much capital to raise is a common question, once that is best addressed by balancing need for cash with dilution of equity. This... Read more
Canadian cannabis company adds Polish hemp grower to European portfolio
A Canadian cannabis company has bought a Polish hemp firm to expand CBD production in Europe. International Cannabis Corp. (ICC) announced Tuesday that it has acquired Polannabis Holdings, which includes a company that grows 850 acres of hemp and has licenses to extract CBD. ICC is paying 2.5 million... Read more
Campaign Blog: Vote Yes on North Dakota Measure 3
by David Owen, Chairman of Legalize North Dakota What Measure 3 does is rather simple. It removes marijuana from the list of Schedule 1 Substances, and as a result, legalizes it for personal consumption, use, distribution, and possession for all North Dakotans over the age of 21. Additionally, it... Read more
Capitalizing on CBD: New market opportunities with athletes
(This is an abridged version of a story that appears in the September issue of Marijuana Business Magazine.) Athletes have long used cannabis products to fight inflammation and recover from injury, but drug-testing rules and marijuana stigma have often kept it a locker-room secret. That’s all changing now, thanks to... Read more
‘One day you’re legal, the next day you’re not’: Confusion from spotty CBD enforcement
CBD producers and retailers in some of the nation’s largest markets say they’re pressing on despite hostile statements from their state regulators that CBD won’t be allowed. Bans in several markets have largely been met with spotty enforcement, CBD entrepreneurs say, and the impact to business has been mixed.... Read more
When cannabis isn’t cannabis – and why hemp may suffer for it
(This is an abridged version of a column that appears in the October issue of Marijuana Business Magazine.) How’s this for irony? The hemp industry’s rush to distance itself from marijuana has gone so far that hemp products can’t be sold in the world’s largest cannabis economy. The development in... Read more
RI allows medical marijuana to treat autism – after trying FDA-approved CBD
A Rhode Island decision to expand medical marijuana access has a worrying caveat for many in the CBD industry: Patients must first try an FDA-approved version of the drug. That classification by the Food and Drug Administration is currently limited to Epidiolex, an epilepsy treatment made by United Kingdom-based pharmaceutical... Read more
Chart: Opportunity in CBD-only stores limited, but strong growth expected for other channels
As state laws around cannabidiol continue to change, stand-alone CBD stores may become a relic. According to estimates from Hemp Industry Daily in the 2018 Hemp & CBD Industry Factbook, CBD sales in the U.S. are expected to exceed $1 billion by 2020. More than half (55%) of retail respondents to a survey for... Read more
Canada hemp changes could disrupt global CBD markets, but US producers hopeful
When Canada’s legal recreational marijuana market launches Wednesday, the nation will also allow its roughly 250 hemp farmers to sell flower for CBD extraction – a change that could have a global impact on CBD prices. “There are a lot of hemp producers who have been saving and drying... Read more
Canadian cannabis company starts US hemp firm, citing looser regulations
Noting hemp’s relaxed oversight compared to marijuana, a Canadian cannabis company has launched a new hemp company and signed a $500,000 CBD deal with a Kentucky hemp producer. Ascent Industries announced the creation of Thirty Eight Hemp Co. to produce CBD products for sale in the United States. Vancouver,... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )